Journal article
Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
- Abstract:
-
Introduction:
Expand abstract
The lack of approved specific therapeutic agents to treat coronavirus disease (COVID‐19) associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has led to the rapid implementation of convalescent plasma therapy (CPT) trials in many countries, including the United Kingdom. Effective CPT is likely to require high titres of neutralising antibody (nAb) in convalescent donations. Understanding the relationship between function...
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, 2.4MB)
-
- Publisher copy:
- 10.1111/tme.12746
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Georg and Emily Von Opel Foundation
More from this funder
European Research Council
More from this funder
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- Transfusion Medicine Journal website
- Volume:
- 31
- Issue:
- 3
- Pages:
- 167-175
- Place of publication:
- England
- Publication date:
- 2020-12-17
- Acceptance date:
- 2020-10-02
- DOI:
- EISSN:
-
1365-3148
- ISSN:
-
0958-7578
- Pmid:
-
33333627
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1150536
- Local pid:
- pubs:1150536
- Deposit date:
- 2021-01-06
Terms of use
- Copyright holder:
- Harvala et al.
- Copyright date:
- 2020
- Rights statement:
- © 2020 The Authors. Transfusion Medicine published by John Wiley & Sons Ltd on behalf of British Blood Transfusion Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
If you are the owner of this record, you can report an update to it here: Report update to this record